Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars
NCT ID: NCT02286648
Last Updated: 2014-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
50 participants
INTERVENTIONAL
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mineral Trioxide Aggregate
pulpotomy with MTA
Mineral Trioxide Aggregate
pulpotomy with MTA
Formocresol
pulpotomy with FC
Formocresol
pulpotomy with formocresol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Formocresol
pulpotomy with formocresol
Mineral Trioxide Aggregate
pulpotomy with MTA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* teeth :
* no clinical or radiographic evidence of pulp degeneration
* the possibility of proper restoration of the teeth
Exclusion Criteria
* excessive bleeding from the exposure site
* internal root resorption
* interradicular and/or periapical bone destruction
* swelling or sinus tract
4 Years
7 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mashhad University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hossein Nematollahi
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mashhad University of Medical Siences
Mashhad, Khorasan Razavi, Iran
Mashhad University of Medical Siences
Mashhad, Khorasan Razavi, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hossein Nematollahi, associate of professor
Role: primary
Homa Noorollahian, associate of professor
Role: backup
Hossein Nematollahi, associate of professor
Role: primary
Homa Noorollahian, associate of professor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
921762
Identifier Type: -
Identifier Source: org_study_id